Underreporting of Vertebral Fractures on Routine Chest Radiography

American Journal of Roentgenology

Volumn 182, Issue 2, 2004, Pages 297-300

  Kim, N ^a   Rowe, B H ^a   Raymond, G ^a   Jen, H ^a   Colman, I ^a   Jackson, S A ^a   Siminoski, K G ^a   Chahal, A M ^a   Folk, D ^a   Majumdar, S R ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIGITAL RADIOGRAPHY; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; OSTEOPOROSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; RADIOGRAPHY; RADIOLOGIST; RANDOMIZATION; RESIDENT; RETROSPECTIVE STUDY; REVIEW; SCREENING; SPINE FRACTURE; THORAX RADIOGRAPHY; VERTEBRA FRACTURE;

EID: 9144228630     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.182.2.1820297     Document Type: Review

References (13)

1. Ross PD. Clinical consequences of vertebral fractures. Am J Med 1997;103(2A)[suppl]:S30-S43
2. Gehlbach SH, Bigelow C, Heimisdottir M, May S, Walker M, Kirkwood JR. Recognition of vertebral fracture in a clinical setting. Osteoporos Int 2000;11:577-582
3. Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003;163:2052-2057
4. Ross PD, Davis JW, Epstein RS. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991;114:919-923
5. Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int 1993;3:120-126
6. Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis: Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 2000;11:83-91
7. Black DM, Thompson DE, Bauer DC, Ensrud R, Musliner T, Hochberg MC. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial-FIT Research Group. J Clin Endocrinol Metab 2000;85:118-124
8. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA 1999;282:1344-1352
9. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999;282:637-645
10. Jackson SA, Tenenhouse A, Robertson L, et al. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos hit 2000;11:680-687
11. Genant HK, Wu CY, Van Kuijk C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-1148
12. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-164
13. Cooper C, Atkinson EJ, O'Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-227